RIA
CLVS

Realta Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Realta Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,500
Closed -$156K – 360
2020
Q1 		$156K Buy
24,500
+21,850
+825% +$175K 0.07% 271
2019
Q4 		$39K Buy
2,650
+2,450
+1,225% +$17.8K 0.01% 736
2019
Q3 		$1K Hold
200
– – ﹤0.01% 1584
2019
Q2 		$3K Hold
200
– – ﹤0.01% 1527
2019
Q1 		$5K Buy
+200
New +$5.01K ﹤0.01% 1088

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Realta Investment Advisors's CLVS Position: Q2 2020 in Review

Realta Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 24,500 shares — an estimated $156K sold.

Realta Investment Advisors first reported a position in CLVS in Q1 2019 and held it in 5 quarters. The position peaked at $156K in Q1 2020. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Realta Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 24,500 Clovis Oncology, Inc. shares in Q2 2020, an estimated $156K.
  • Realta Investment Advisors first reported a position in Clovis Oncology, Inc. in Q1 2019 and held it in 5 quarters.
  • Realta Investment Advisors's Clovis Oncology, Inc. position peaked at $156K in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Realta Investment Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.